Pascal and Francis Bibliographic Databases

Help

Search results

Your search

ct.\*:("Vascular wall")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1921

  • Page / 77
Export

Selection :

  • and

Mitochondrial bioenergetics and therapeutic intervention in cardiovascular diseaseMERCER, John R.Pharmacology & therapeutics (Oxford). 2014, Vol 141, Num 1, pp 13-20, issn 0163-7258, 8 p.Article

PI-3 Kinase-PTEN Signaling Node : An Intercept Point for the Control of Angiogenesis : Angiogenesis agentsCASTELLINO, R. C; MUH, C. R; DURDEN, D. L et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 4, pp 380-388, issn 1381-6128, 9 p.Article

Intracellular targets of matrix metalloproteinase-2 in cardiac disease : Rationale and therapeutic approachesSCHULZ, Richard.Annual review of pharmacology and toxicology. 2007, Vol 47, pp 211-242, issn 0362-1642, 32 p.Article

Trends in vascular biology; functional restoration of damaged endotheliumRODRIGUEZ-FEO, Juan A; PASTERKAMP, Gerard.Current pharmaceutical design. 2007, Vol 13, Num 17, issn 1381-6128, 103 p.Serial Issue

Experimental antioxidant biotherapy for protection of the vascular wall by modified forms of superoxide dismutase and catalase : Oxidative balance: Experimental and clinical perspectivesMAKSIMENKO, Alexander V.Current pharmaceutical design. 2005, Vol 11, Num 16, pp 2007-2016, issn 1381-6128, 10 p.Article

What do we know about apolipoprotein E and the prevention of cardiovascular disease?TAN, Chee-Eng; SHYONG TAI, E.Drug development research. 2004, Vol 62, Num 3, pp 200-206, issn 0272-4391, 7 p.Article

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodiesJAYNE, David; RASMUSSEN, Niels; GROSS, Wolfgang et al.The New England journal of medicine. 2003, Vol 349, Num 1, pp 36-44, issn 0028-4793, 9 p.Article

Age-related changes in the protective effect of chronic administration of L-arginine on post-ischemic recovery of endothelial functionNAKAMURA, Koki; AL-RUZZEH, Sharif; CHESTER, Adrian H et al.European journal of cardio-thoracic surgery. 2003, Vol 23, Num 4, pp 626-632, issn 1010-7940, 7 p.Article

Effects of aspirin on N-α-tosyl L-arginine methyl ester [TAME]-esterase induced contractions on rat aorta in vitroFATMAH BIBI HOUSNAH GURIB; ANWAR HUSSEIN SUBRATTY.Fundamental & clinical pharmacology. 2003, Vol 17, Num 1, pp 71-75, issn 0767-3981, 5 p.Article

Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivoHSIAO, George; SHEN, Ming-Yi; LIN, Kuan-Hung et al.European journal of pharmacology. 2003, Vol 465, Num 3, pp 281-287, issn 0014-2999, 7 p.Article

Propagermanium suppresses macrophage-mediated formation of coronary arteriosclerotic lesions in pigs in vivoSHIMOKAWA, Hiroaki; ETO, Yasuhiro; MIYATA, Kenji et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 3, pp 372-380, issn 0160-2446, 9 p.Article

Systemic α1A-adrenoceptor antagonist inhibits neointimal growth after balloon injury of rat carotid arteryTEETERS, John C; ERAMI, Cauveh; HUA ZHANG et al.American journal of physiology. Heart and circulatory physiology. 2003, Vol 53, Num 1, pp H385-H392, issn 0363-6135Article

The LONFLIT4-venoruton study: A randomized trial: Prophylaxis of flight-edema in venous patientsCESARONE, Maria Rosaria; BELCARO, Gianni; CANDIANI, Carlo et al.Angiology. 2003, Vol 54, Num 2, pp 137-142, issn 0003-3197, 6 p.Article

Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokersGUTHIKONDA, Sashi; SINKEY, Christine; BARENZ, Therese et al.Circulation (New York, N.Y.). 2003, Vol 107, Num 3, pp 416-421, issn 0009-7322, 6 p.Article

Captopril restores endothelium-dependent relaxation of rat aortic rings after exposure to homocysteineFU, Yun-Feng; YAN XIONG; FU, Si-Hai et al.Journal of cardiovascular pharmacology. 2003, Vol 42, Num 4, pp 566-572, issn 0160-2446, 7 p.Article

Chemical synthesis and microvascular effects of new nitric oxide donors in humans. CommentaryKHAN, Faisel; PEARSON, Russell J; NEWTON, David J et al.Clinical science (1979). 2003, Vol 105, Num 5, pp 533-535, issn 0143-5221, 11 p.Article

Evidence favoring the use of an α2-Selective vasopressor agent for cardiopulmonary resuscitationPELLIS, Tommaso; WEIL, Max Harry; WANCHUN TANG et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 21, pp 2716-2721, issn 0009-7322, 6 p.Article

Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated ratsSPRONK, H. M. H; SOUTE, B. A. M; SCHURGERS, L. J et al.Journal of vascular research. 2003, Vol 40, Num 6, pp 531-537, issn 1018-1172, 7 p.Article

Nifedipine inhibits tumor necrosis factor-α-induced monocyte chemoattractant protein-1 overexpression by blocking NADPH oxidase-mediated reactive oxygen species generationYAMAGISHI, S; INAGAKI, Y; KIKUCHI, S et al.Drugs under experimental and clinical research. 2003, Vol 29, Num 4, pp 147-152, issn 0378-6501, 6 p.Article

A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humansEPPLER, Stephen M; COMBS, Daniel L; HENRY, Timothy D et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 1, pp 20-32, issn 0009-9236Article

Influence of severe renal dysfunction on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonistDINGEMANSE, J; VAN GIERSBERGEN, P. L. M.International journal of clinical pharmacology and therapeutics. 2002, Vol 40, Num 7, pp 310-316, issn 0946-1965Article

Lysophosphatidylcholine potentiates vascular contractile responses in rat aorta via activation of tyrosine kinaseSUENAGA, Hiroshi; KAMATA, Katsuo.British journal of pharmacology. 2002, Vol 135, Num 3, pp 789-799, issn 0007-1188Article

Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 1. Synthesis, structure-activity relationship, and biological effects of a new class of quinazoline derivativesMATSUNO, Kenji; ICHIMURA, Michio; LOKKER, Nathalie A et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 14, pp 3057-3066, issn 0022-2623Article

Efficacy, routine effectiveness, and safety of horsechestnut seed extract in the treatment of chronic venous insufficiency: A meta-analysis of randomized controlled trials and large observational studiesSIEBERT, U; BRACH, M; SROCZYNSKI, G et al.International angiology. 2002, Vol 21, Num 4, pp 305-315, issn 0392-9590, 11 p.Article

Formulating clinical strategies for angiotensin antagonism : A review of preclinical and clinical studiesTABIBIAZAR, Raymond; JAMALI, Aamer H; ROCKSON, Stanley G et al.The American journal of medicine. 2001, Vol 110, Num 6, pp 471-480, issn 0002-9343Article

  • Page / 77